Eli Lilly is slashing insulin prices by 70%. Have we entered a new era of drug affordability or is this announcement just a lot of hot air?
TOPICS
(0:34) Is the Eli Lilly’s Insulin price cut a big deal?
(2:07) What does the price cut mean for Americans who need Insulin?
(5:41) Why is Eli Lilly reducing the prices now?
(6:28) How have Insulin prices affected diabetics in the past?
(8:08) Why is Insulin so expensive in the United States?
(9:17) Who are the major players in the Insulin market?
(11:22) What will this cut mean for other drug pricing, drug companies and consumer costs?
(12:56) Does Lilly Stand to lose money from this decision?
ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
JOIN OUR NEWSLETTER: [ Ссылка ]
GET IN TOUCH
Become a CareTalk Podcast sponsor: [ Ссылка ]
Guest appearance requests: [ Ссылка ]
Visit us at [ Ссылка ]
FOLLOW
Spotify: [ Ссылка ]......
Apple Podcasts: [ Ссылка ]......
Follow us on LinkedIn: [ Ссылка ]
PRODUCED BY:
Grippi Media: [ Ссылка ]
#insulin #elililly ##healthcare #healthcarepodcast #caretalk
